Abstract
Background and aims
Age-related macular degeneration (AMD) is a leading cause of severe and irreversible visual loss, affecting the population aged 40 years and older [1] . According to the World Health Organization, AMD is more frequent in developed countries [2] . It is estimated that nearly 8 million people will be affected with AMD by the year 2020 [3] .
There are 2 types of AMD: the wet (exudative, neovascular) form that is responsible for 10-20% of the cases, with a fast and severe visual loss and the dry (non-exudative, nonneovascular) form with a slower and progressive evolution.
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In the pathogenesis of AMD, there were cited non modifiable risk factors such as advanced age, sex and genes. Different studies associated AMD with modifiable risk factors such as cigarette smoking, hypertension, elevated values of cholesterol, diabetes and cataract surgery [4] [5] [6] [7] [8] [9] .
The investigation of risk factors for AMD is essential in understanding the pathogenesis and progression of the disease, but the most important is to identify preventive measures and better treatments.
The aim of our study was to evaluate the association between the potential risk factors and the different stages of AMD in a population aged 52-85 years.
Material and method
We evaluated one hundred and ten patients with diagnosed AMD who required medical services in the period April-July 2013 within the Ophthalmology Department of the University of Szeged. After obtaining informed consent, the patients underwent a medical interview and a complete ophthalmological examination. The study respected the Helsinki Declaration and was approved by the Ethical Board of the University of Szeged.
Clinical data were collected from all patients using direct and detailed patient interview focusing on sex, age, general and ocular diseases history, history of ocular surgery and personal habits such as cigarette smoking. Arterial hypertension, diabetes and dyslipidemia were considered present if the patient was previously diagnosed by an internal medicine specialist with or without current usage of medications. History of duration of these diseases was also documented. For the smoking habit, the first question was if the patient ever smoked. If the answer was positive, the patient was asked for how long he or she had been smoking (years), the number of cigarettes (per day) and the actual status (still smoking/stopped smoking and for how long).
The ophthalmological examination was performed after pupil dilatation with NeoSynephrine and included identification and measurement of the macular lesions using the Spectral Domain Optical Coherence Tomograph (SD-OCT), Heidelberg Engineering, from the Ophthalmology Department of the University of Szeged.
The AMD was graded according to the International Classification and Grading System for Age-Related Maculopathy in 5 stages: no signs of AMD or the presence of one small drusen <63µm as stage 0; soft distinct drusen (≥ 63µm and < 125 μm) or only pigmentary abnormalities as stage 1. Early AMD includes stage 2 with soft distinct drusen (≥125 µm), reticular drusen only, or soft distinct drusen (≥63 µm and < 125 μm) with pigmentary abnormalities and stage 3 where the pigmentary abnormalities are associated with bigger dimensions of the reticular drusen or soft distinct drusen (≥125 µm) as shown in Figure 1 .
Stage 4 (also known as late AMD) is divided in 2 types: the dry form (geographic atrophy)-demarcated area, larger than 175 µm with the apparent absence of the retinal pigment ephitelium (RPE) and visible choroidal vessels ( Figure 2 ) and the wet-AMD (Figure 3 ) defined by the presence of a RPE detachment (serous or hemorrhagic) and/or subretinal hemorrhage, and/or subretinal neovascular membrane, and/or periretinal fibrous scar [10, 11] .
Lesions that could be considered to be the results of other diseases such as: chorioretinitis, ocular trauma, high myopia or congenital diseases defined the exclusion criteria. We also excluded the patients with evolved cataract opacities that could interfere with the fundus examination and staging of the AMD.
The statistical analysis was performed using EpiInfo 7. 
Results
In our study from 110 patients, 76 were females (69.1%) and 34 males (30.9%). Patients were aged between 52 and 85 years, with a medium age of 71 years. 42 of the patients in the study group (38.18%) were diagnosed with stage 1 of AMD, 14 (12.72%) with stage 2, 13 (11.18%) with stage 3 and 41 (37.27%) with stage 4.
When analyzing the association between age and the stage of the ocular disease, we found that age above 70 years is statistically significantly associated with stages 3 and 4 of the disease: OR=6.55 (2.84 -15.08), p<0.001 (Figure 4) . We analyzed the obtained data, taking into account the presence of the risk factors and also the duration (in years) of the associated diseases.
Type 2 diabetes mellitus (T2DM) was present in 32 patients (29.1%): 22 females (68.75%) and 10 males (31.25%) and was associated with late-AMD if the history of the diabetes was more than 6-10 years ( Figure 5 ).
In patients with no history of T2DM, we identified more frequently drusens and pigmentary abnormalities characteristic for the stages 1 or 2 of AMD (Figure 6 (Figure 7) . Furthermore, a history of hypertension for longer than 5 years seems to be associated with advanced stages of AMD (Figure 8) .
Dyslipidemia was present in 75 patients (68.2%): 52 females (69.3%) and 23 males (30.7%). Patients with dyslipidemia had all 4 stages of AMD (Figure 9 ). We have investigated the possible association between dyslipidemia and presence of advanced stages of AMD and found a statistical significant relationship between dyslipidemia and stage 4 of AMD: OR=2.65 (1.06 -6.59), p=0.01. As shown in Figure 10 , patients with a more recent onset of dyslipidemia had more frequently stage 1 AMD.
In our study group we identified 43 patients (39.1%) with a history of smoking or still active smokers: 32 females (74.4%) and 11 males (25.6%). When analyzing the association between smoking and the stage of AMD, we found that smoking (present or past) is significantly associated with stages 3 and 4 of the disease: OR= 5 (1.53 -16.24), p= 0.002 (Figure 11) .
Of the 43 patients with a history of smoking, 24 were active smokers (55.8%): 20 females (83.3%) and 4 males (16.7%). A smoking history longer than 20 years was present especially in patients with late AMD (Figure 12 ). Pseudophakia was present in 24 patients (21.8%): 18 females (75%) and 6 males (25%). When analyzing the association between the presence of pseudophakia and the stage of AMD, we found no statistical significant association between them: p=0.06 ( Figure 13 ).
The distribution of the patients according to the stage of the AMD and the duration of pseudophakia showed us that patients with cataract surgery performed more than 5 years ago had only stage 4 of the macular disease ( Figure 14) . 
Discussions
As it is reported in different studies worldwide, age is the most important non modifiable risk factor associated with AMD [12] [13] [14] [15] . In our study, we identified that the prevalence of the late stages of AMD is higher in patients older than 70. The Hisayama Study from Japan, performed in a population aged 50 years and older, identified a prevalence of early AMD of 12.7% and of late AMD of 0.87% [16] . The Shihpai Eye Study from Taiwan confirmed the importance of age in the pathology of early and late AMD, but after comparing subject groups with different ages, the authors conclude that early AMD is more frequent after the age of 69 and late AMD after 85 years old [17] . Their results in the age group 65-74 years are similar with those reported in other studies such as the Multiethnic Study of Atherosclerosis (MESA) [18] . In this study, the prevalence of AMD was higher in White (5.5%), Hispanics (4.5%) and Chinese (5.0%) people, but lower in Blacks (2.1%). In the Beijing Eye Study the prevalence of AMD was 2.5% [8] . The Andhra Pradesh Eye Disease Study showed that the adjusted prevalence of AMD was significantly higher in subjects aged 60 years or older: OR= 3.55 (1.61-7.82) [19] .
Smoking is the most consistent modifiable risk factor associated with AMD [20, 21] . Thus, the review of 13 studies found a statistically significant association between smoking and AMD, with increased risks for active-smokers or subjects with a history of smoking compared with never-smokers [22] . The South Indian Andhra Pradesh Study (2005) identified a higher prevalence of AMD in the smokers group compared with never smokers. This study also reported a non-statistically significant association with the different types and quantities of nicotine by comparing the home made traditional cigars with the classical filtered cigarettes [19] . The Shihpai Eye Study identified smoking as a non significant risk factor for AMD [17] . [26] . The Andhra Pradesh Eye Disease Study in South India found no association with arterial hypertension, but identified higher odds of AMD in the hypertensive patients group [19] .
A publication from 2007, within the AREDS study, concluded that a protective factor for AMD may be a reduced glycaemic index in nondiabetic subjects [31, 32] . In our study we identified that late-AMD is associated with a history of diabetes of more than 6-10 years.
AMD after cataract surgery has been identified in different studies. The Andhra Pradesh Eye Disease Study, the Beaver Dam Eye Study and the Blue Mountains Eye Study demonstrated an association between cataract surgery and AMD [19, 33, 34] . In our study we haven't found a statistical significant association between pseudophakia and AMD.
Our study has several limitations. First, due to the small size of our study group, the statistical conclusions cannot be extended to the general population aged over 50 years. According to literature the female sex is more affected by the AMD disease, but taking into account the number of our patients we cannot conclude. Another limitation of the study is that we could not identify from the history of previous ophthalmological examination if the patients that underwent cataract surgery had before or after the medical procedure the characteristic AMD modifications.
Conclusions
In summary, we have observed different associations between AMD and modifiable risk factors. Avoiding smoking and control of diabetes, hypertension and dyslipidemia have the potential to reduce the risk of developing AMD. However, further investigation is needed to identify and to clarify the association between these possible risk factors and AMD.
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